Head of Cancer Epigenetics team;
Main research activities:
I. Investigation of epigenetic mechanisms involved in tumorigenesis
II. Identification and characterization of new epigenetic modulators
III. Investigation of mechanisms by which epigenetic modulators induce anti-tumor activities for preventive and therapeutic purposes
Michael Schnekenburger
Team leader of “Cancer epigenetics” research group
Summary
Published articles Show More
The HDAC6 inhibitor 7b induces BCR-ABL ubiquitination and downregulation and synergizes with imatinib to trigger apoptos...
...Published in Pharmacological Research
Despite the discovery of tyrosine kinase inhibitors (TKIs) for the treatment of breakpoint cluster region-Abelson (BCR-ABL) + cancer types, patients with chronic myeloid leukemia (CML) treated with TKIs develop resistance and severe adverse effects. Combination treatment, especially with a histone deacetylase (HDAC) 6 inhibitor (HDAC6i), appears to...
Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/M...
...Published in Clinical Epigenetics
Background: Chronic myeloid leukemia (CML) pathogenesis is mainly driven by the oncogenic breakpoint cluster region-Abelson murine leukemia viral oncogene homolog 1 (BCR-ABL) fusion protein. Since BCR-ABL displays abnormal constitutive tyrosine kinase activity, therapies using tyrosine kinase inhibitors (TKis) such as imatinib represent a major bre...
Discovery and Characterization of R/S-N-3-Cyanophenyl-N'- (6-tert-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2H- 1-ben...
...Published in Journal of Medicinal Chemistry
A new series of N-aryl-N'-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)ureas bearing an alkoxycarbonylamino group at the 6-position were synthesized and examined as putative anticancer agents targeting sirtuins in glioma cells. Based on computational docking combined to in vitro sirtuin 1/2 inhibition assays, we selected compound 18 [R/S-N-3-cyano...
Experience
Team leader of “Cancer epigenetics” research group Since August 2007
Laboratoire de Biologie Moléculaire et Cellulaire du Cancer (LBMCC) (Luxembourg LU)
Role, mechanisms and therapeutic potential of epigenetics in cancer
Post-doctoral fellow April 2005 - July 2007
University of Cincinnati (Cincinnati US)
Department of Environmental Health
PhD student November 2001 - March 2005
Laboratoire de Biologie Moléculaire et Cellulaire du Cancer (LBMCC) (Luxembourg LU)
Recipient of a grant from the Luxembourgish government
Internship September 2000 - August 2001
University of Reims Champagne-Ardenne (Reims FR)
Laboratoire de Spectroscopie Biomoléculaire; Unité MéDian, CNRS FRE 2141, IFR 53, Faculty of Pharmacy
Internship November 1999 - April 2000
University of Reims Champagne-Ardenne (Reims FR)
Laboratory of parasitology
Education
PhD September 2001 - December 2004
University of Reims Champagne-Ardenne (Reims FR)
PhD thesis in molecular and cellular biology
MSc September 1999 - July 2001
University of Reims Champagne-Ardenne (Reims FR)
Biochemistry; 1st year: Faculty of Sciences, 2nd year: Faculty of Pharmacy
BSc September 1997 - July 1999
University of Reims Champagne-Ardenne (Reims FR)
Life sciences-Biochemistry; Faculty of Sciences
Awards
Poster presentation award May 2006
Post-doctoral scholars research forum (Cincinnati, Ohio, USA)
PhD scholarship November 2001
From the Ministry for Higher Education and Research in Luxembourg (2001-2004)